Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
We asked Associate Professor Abraham Flaxman the question how we can use the Global Burden of Disease study to achieve Sustainable Development Goal 3.2.